Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALACTIC: Obinutuzumab as Consolidation Therapy in CLL
2014-000880-42Phase 2Unknown
- Sponsor
- University of Leeds
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) comparing Obinutuzumab consolidation with No consolidation (observation) (2 arms). Status: unknown.
02
Drugs
obinutuzumab
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2014-000880-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000880-42.